Clinical Trial Update: Multimodal Imaging Analysis During Treatment With Bevacizumab in Patients With Recurrent Glioblastoma [NA]

View source ↗

Summary

This clinical trial update notes the termination of a study evaluating multimodal imaging analysis during Bevacizumab treatment in patients with recurrent gliob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Glioblastoma | NA | Status: TERMINATED